XML 71 R60.htm IDEA: XBRL DOCUMENT v3.20.2
Geneos Therapeutics, Inc. - Fair Value Assumptions (Details) - Geneos Therapeutics, Inc.
$ in Thousands
Jun. 01, 2020
USD ($)
Noncontrolling Interest [Line Items]  
Geneos enterprise value $ 4,966,531
Measurement input, expected term  
Noncontrolling Interest [Line Items]  
Equity method investment, measurement input, expected term 2 years 11 months 1 day
Measurement input, price volatility  
Noncontrolling Interest [Line Items]  
Equity method investment, measurement input 0.70
Measurement input, risk free interest rate  
Noncontrolling Interest [Line Items]  
Equity method investment, measurement input 0.0246